OPEN END TURBO OPTIONSSCHEIN SHORT - MERCK & CO. | Market Closed - BOERSE MUENCHEN 19:26:20 24/05/2024 BST | ||
| 4.398 EUR | +2.76% |
|
| Current month | -2.16% | ||
| 1 month | -5.32% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 24/05/24 | 4.398 | +2.76% |
| 23/05/24 | 4.28 | +0.71% |
| 22/05/24 | 4.25 | -0.91% |
| 21/05/24 | 4.289 | +2.00% |
| 20/05/24 | 4.205 | -1.08% |
Real-time BOERSE MUENCHEN
Last update May 24, 2024 at 07:26 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | MERCK & CO., INC. |
| Issuer | Goldman Sachs |
| WKN | GG2DE0 |
| ISIN | DE000GG2DE08 |
| Date issued | 10/01/2024 |
| Strike | 177.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 5.38 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.52 € |
|---|---|
| Lowest since issue | 4.11 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.5
USD
Average target price
141.9
USD
Spread / Average Target
+9.57%
- Stock Market
- Certificates
- Certificat
